We are live on ! Find out more
Rockefeller Capital Management

Rockefeller Capital Management Portfolio holdings

AUM $56.4B
1-Year Est. Return 24.96%
This Fund
S&P 500
This Quarter Est. Return
+16.85%
1 Year Est. Return
+24.96%
3 Year Est. Return
+83.53%
5 Year Est. Return
+100.91%
10 Year Est. Return
AUM
$13.2B
AUM Growth
+$2.53B
Cap. Flow
+$1B
Cap. Flow %
7.59%
Top 10 Hldgs %
23.93%
Holding
3,118
New
401
Increased
1,400
Reduced
617
Closed
168

Top Buys

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$120M
2
GL icon
Globe Life
GL
+$115M
3
MPT
Medical Properties Trust
MPT
+$91.5M
4
ACGL icon
Arch Capital
ACGL
+$69.2M
5
AMZN icon
Amazon
AMZN
+$45.6M

Top Sells

Rank Stock Value
1
PGR icon
Progressive
PGR
+$138M
2
GSK icon
GSK
GSK
+$98.7M
3
CCK icon
Crown Holdings
CCK
+$92.3M
4
AWK icon
American Water Works
AWK
+$54M
5
SEDG icon
SolarEdge
SEDG
+$45.7M

Sector Composition

Rank Sector Weight
1 Technology 20.64%
2 Financials 15.05%
3 Healthcare 13.07%
4 Consumer Discretionary 9.61%
5 Communication Services 7.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CEVA icon
2851
CEVA Inc
CEVA
$1.08B
-483
Closed -$19K
CHCT
2852
Community Healthcare Trust
CHCT
$454M
$0 ﹤0.01%
21
CHT icon
2853
Chunghwa Telecom
CHT
$33B
-207
Closed -$7K
CLOV icon
2854
Clover Health Investments
CLOV
$2.51B
-905
Closed -$11K
CMCO icon
2855
Columbus McKinnon
CMCO
$584M
$0 ﹤0.01%
7
CMP icon
2856
Compass Minerals
CMP
$1.15B
$0 ﹤0.01%
+15
New +$929
CNDT icon
2857
Conduent
CNDT
$264M
$0 ﹤0.01%
104
-207
-67% -$864
CNTY icon
2858
Century Casinos
CNTY
$34M
-730
Closed -$4K
COLL icon
2859
Collegium Pharmaceutical
COLL
$956M
-723
Closed -$15K
COOP
2860
DELISTED
Mr. Cooper
COOP
-4
Closed
CORT icon
2861
Corcept Therapeutics
CORT
$12B
$0 ﹤0.01%
+5
New +$105
COWZ icon
2862
Pacer US Cash Cows 100 ETF
COWZ
$19.4B
$0 ﹤0.01%
+22
New +$682
CRBP icon
2863
Corbus Pharmaceuticals
CRBP
$190M
$0 ﹤0.01%
17
CRTO icon
2864
Criteo S.A. Ordinary Shares
CRTO
$923M
-349
Closed -$4K
CUK
2865
DELISTED
Carnival PLC
CUK
-56
Closed
CVEO icon
2866
Civeo
CVEO
$318M
$0 ﹤0.01%
47
-1
-2% -$12
CWK icon
2867
Cushman & Wakefield Ltd
CWK
$3.25B
-143
Closed -$1K
CYRX icon
2868
CryoPort
CYRX
$762M
-6,232
Closed -$295K
DBO icon
2869
Invesco DB Oil Fund
DBO
$366M
-3,800
Closed -$27K
DBP icon
2870
Invesco DB Precious Metals Fund
DBP
$255M
$0 ﹤0.01%
15
KUST
2871
Kustom Entertainment Inc
KUST
$759K
0
-$21K
DK icon
2872
Delek US
DK
$3.58B
$0 ﹤0.01%
20
+3
+18% +$40
DRRX
2873
DELISTED
DURECT Corp
DRRX
-1,300
Closed -$22K
DTIL icon
2874
Precision BioSciences
DTIL
$207M
-767
Closed -$141K
DVAX
2875
DELISTED
Dynavax Technologies
DVAX
$0 ﹤0.01%
+142
New +$643

Similar funds

Rockefeller Capital Management's Q4 2020 Portfolio in Review

As of Q4 2020, Rockefeller Capital Management held 3,118 positions worth $13.2B, up 24% from $10.7B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Rockefeller Capital Management deployed $1B of net new capital in Q4 2020, opening 401 new positions and adding to 1,400 existing holdings. Its largest new stake was BridgeBio Pharma: 777,031 shares worth $55.3M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 21% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Progressive, an estimated $138M trimmed.

  • Rockefeller Capital Management's largest Q4 2020 buy was BridgeBio Pharma: 777,031 shares worth $55.3M.
  • Rockefeller Capital Management added most to Alibaba in Q4 2020, an estimated $120M increase.
  • Rockefeller Capital Management's biggest Q4 2020 reduction was Progressive, cutting an estimated $138M.
  • Rockefeller Capital Management fully exited Unilever NV New York Registry Shares in Q4 2020, selling an estimated $1.67M.
  • Rockefeller Capital Management's ten largest holdings make up 24% of its $13.2B portfolio in Q4 2020.
  • Rockefeller Capital Management opened 401 new positions and closed 168 in Q4 2020.
  • Rockefeller Capital Management's portfolio value rose 24% quarter-over-quarter to $13.2B.

Based on Rockefeller Capital Management's 13F filing for Q4 2020, filed 12 Feb 2021.